3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Non-Small-Cell Lung
3
Head and Neck Neoplasms
2
Tongue Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrent Head and Neck Carcinoma
1
Precancerous Conditions
1
Pleural Effusion, Malignant
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Leukoplakia, Oral
1
Laryngeal Neoplasms
1
Barrett Esophagus
1
Interventions
Fluorouracil
34
Cisplatin
34
Radiotherapy
30
Oxaliplatin
30
Paclitaxel
22
pembrolizumab
20
Irinotecan
20
Docetaxel
20
Leucovorin
19
Capecitabine
16
Cetuximab
11
Carboplatin
11
Bevacizumab
11
Radiation
10
Surgical Procedures, Operative
9
Trastuzumab
8
Panitumumab
6
Epirubicin
6
Neoadjuvant Therapy
5
Esophagectomy
4
Erlotinib Hydrochloride
4
Chemotherapy, Adjuvant
4
tisotumab vedotin
3
durvalumab
3
Sunitinib
3
Microarray Analysis
3
Immunohistochemistry
3
Gene Expression Profiling
3
Gemcitabine
3
Albumin-Bound Paclitaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Neoplasms
×
Dihematoporphyrin Ether
×
Clear all
No trials found.